🔓 Unlock the full profile of Satyanarayana Chava (Founder And Ceo At Laurus Labs), including verified contact details, financial insights, and professional associations.
See Satyanarayana Chava Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sat*****@fou******.com
Mobile: 96673*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Satyanarayana Chava founded Laurus Labs in 2005 and has been instrumental in its transformation into a leading integrated pharmaceutical company.
- Under his leadership, Laurus Labs has achieved significant growth and innovation in the pharmaceutical industry, focusing on providing high-quality solutions.
- Chava holds both a master's degree and a Ph.D. in chemistry, showcasing his strong academic background that supports his expertise in the pharmaceutical field.
- In March 2024, he received the Best CEO Award in Pharma & Health Care from Business Today, reflecting his leadership excellence in the industry.
- He has overseen numerous strategic initiatives that enhanced Laurus Labs’ capabilities in manufacturing and research and development of pharmaceutical products.
- Chava has contributed to expanding the company's global presence, successfully navigating competitive challenges in the pharmaceutical sector.
- His vision for Laurus Labs includes continuous improvement, sustainability in operations, and a commitment to enhancing patient outcomes worldwide.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| L24239AP2005PLC047518 | Laurus Labs Limited | Whole-time director | 21 Jan 2006 |
| U02423KA2005PTC036770 | Laurus Bio Private Limited | Director | 20 Jan 2021 |
| U21000TS2024FTC184449 | Krka Pharma Private Limited | Director | 12 Apr 2024 |
| U24239TG2004NPL043058 | Pharmaceuticals Export Promotion Council Of India | Director | 25 Apr 2018 |
| U72200TG2005PTC046163 | Nowpos M-Solutions Private Limited | Director | 31 Dec 2005 |
| U72300TG2014PTC092281 | Chemiasoft Private Limited | Director | 10 Jan 2014 |
| U74999MH2018PTC315497 | Immunoadoptive Cell Therapy Private Limited | Nominee Director | 09 Dec 2021 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|---|---|---|
| U33112KA2011PLC059915 | S3v Vascular Technologies Limited | Director | 30 Sep 2013 | 07 August 2015 |
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Laurus Labs Ltd. | Executive Director & CEO | 13.5 Cr | -27.7 % |
| 2023 | Laurus Labs Ltd. | Executive Director & CEO | 18.6 Cr | -32.3 % |
| 2022 | Laurus Labs Ltd. | Executive Director & CEO | 27.5 Cr | 54.1 % |
| 2021 | Laurus Labs Ltd. | Executive Director & CEO | 17.9 Cr | 123.8 % |
| 2020 | Laurus Labs Ltd. | Executive Director & CEO | 8.0 Cr | -35.8 % |
| 2019 | Laurus Labs Ltd. | Executive Director | 12.4 Cr | -0.2 % |
| 2018 | Laurus Labs Ltd. | Executive Director & CEO | 12.5 Cr | 28.9 % |
| 2017 | Laurus Labs Ltd. | Whole Time Director & CEO | 9.7 Cr | - |
| 2016 | Laurus Labs Ltd. | Whole Time Director & CEO | - | - |